设计和实施一个基于网络的平台,用于准确和可靠的临床结果测量和全球认证,用于评估Charcot-Marie-Tooth疾病
Kayla M D Cornett1,2, Tim Estilow3, Paula Bray1,2
1School of Health Sciences, Faculty of Medicine & Health, The University of Sydney, Sydney, New South Wales, Australia.
Journal of the peripheral nervous system : JPNS
|September 18, 2025
概括
一个新的网络平台和全球认证标准提高了Charcot-Marie-Tooth (CMT) 结果测量准确度. 该资源提供标准化培训和实时评分,对于罕见神经疾病研究和治疗评估至关重要.
科学领域:
- 神经学 神经学
- 临床试验 临床试验
- 数字健康数字健康
背景情况:
- 准确的临床结果测量对于罕见的神经疾病如Charcot-Marie-Tooth (CMT) 至关重要.
- 可访问的成果措施 (CMTPedS,CMTInfS,CMT-FOM) 减少了实施障碍.
- 标准化评估对于监测疾病进展和治疗疗效至关重要.
研究的目的:
- 设计一个基于网络的平台,用于实时评分CMT结果指标.
- 为临床评估人员实施共同设计的培训和质量保证资源.
- 为CMT临床评估人员建立全球认证标准.
主要方法:
- 咨询过程和用户评估 (n=65) 告知了平台设计.
- 培训资源与利益相关者 (n=51) 共同设计,包括患者和医生.
- 全球认证标准是通过共同设计和主教练专业知识开发的.
主要成果:
- 一个免费的网络平台 (ClinicalOutcomeMeasures.org) 在2020年6月推出,现在拥有来自45多个国家的1400多名用户.
- 缺乏可访问的培训被确定为准确的CMT结果测量管理的主要障碍.
- 视频演示,在线研讨会和标记照片是首选的培训方法;建立了五个认证原则.
结论:
- 该网络平台可方便实时评分CMT结果指标.
- 标准化培训和全球认证标准提高了评估的准确性和可靠性.
- 本资源支持有效评估疾病严重程度,进展和治疗疗效在CMT.
相关概念视频
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
364
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
364


